Literature DB >> 11243980

Positron emission tomography in the staging of small-cell lung cancer : a preliminary study.

H P Hauber1, K H Bohuslavizki, C H Lund, A Fritscher-Ravens, A Meyer, A Pforte.   

Abstract

STUDY
OBJECTIVES: Small-cell lung cancer (SCLC) has an unfavorable prognosis, especially when the disease is extensive at presentation. Accurate staging procedures are therefore needed for treatment planning. Positron emission tomography (PET) is a modern noninvasive imaging technique, the value of which for the staging of SCLC was investigated in the present study.
SETTING: University hospital. PATIENTS: Thirty-one patients with suspected lung cancer were investigated for staging purposes using chest radiography, CT of the thorax and abdomen, abdominal ultrasound, and bone scanning. Twenty-five patients also received PET examinations during the staging procedures. Five of these patients were found to have SCLC, while two patients had mixed lesion types. Further analysis of the latter group was carried out.
RESULTS: PET detected the primary tumor in all patients, and lymph nodes in five patients. All lymph nodes were proved to be malignant by endoscopic ultrasonography-guided fine-needle aspiration. Only one patient had distant metastases, which were detected by both CT and PET.
CONCLUSIONS: PET appears be a suitable imaging method in SCLC. A potential role for the technique as a standard staging procedure will need to be tested by investigating a larger number of patients in a prospective study.

Entities:  

Mesh:

Year:  2001        PMID: 11243980     DOI: 10.1378/chest.119.3.950

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Subcarinal node is the significant node that affects survival in resected small cell lung cancer.

Authors:  Masaki Miyamoto; Toshiaki Morikawa; Kichizo Kaga; Setsuyuki Ohtake; Yasushi Cho; Satoshi Hirano; Satoshi Kondo
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.

Authors:  I Brink; T Schumacher; M Mix; S Ruhland; E Stoelben; W Digel; M Henke; N Ghanem; E Moser; E U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-17       Impact factor: 9.236

3.  Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.

Authors:  Thierry Jacob; Dany Grahek; Nassima Younsi; Khaldoun Kerrou; Nicolas Aide; Françoise Montravers; Sonia Balogova; Cecile Colombet; Virginie De Beco; Jean N Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-10       Impact factor: 9.236

4.  Early assessment of therapeutic response using FDG PET in small cell lung cancer.

Authors:  Y Yamamoto; R Kameyama; M Murota; S Bandoh; T Ishii; Y Nishiyama
Journal:  Mol Imaging Biol       Date:  2009-05-12       Impact factor: 3.488

Review 5.  18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.

Authors:  Sona Balogova; Jean-Noël Talbot; Valérie Nataf; Laure Michaud; Virginie Huchet; Khaldoun Kerrou; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-16       Impact factor: 9.236

Review 6.  Management of small cell lung cancer.

Authors:  Kristen Keon Ciombor; Caio Max S Rocha Lima
Journal:  Curr Treat Options Oncol       Date:  2006-01

Review 7.  Staging and imaging of small cell lung cancer.

Authors:  Gregory P Kalemkerian
Journal:  Cancer Imaging       Date:  2012-01-12       Impact factor: 3.909

Review 8.  The impact of functional imaging on radiation medicine.

Authors:  Nidhi Sharma; Donald Neumann; Roger Macklis
Journal:  Radiat Oncol       Date:  2008-09-15       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.